Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BICO & VITK -- Ignore unavailable to you. Want to Upgrade?

To: Rosemary Soldberg who wrote (2163)	9/23/1998 4:14:00 PM
From: Tom R. Jones	Read Replies (1) \| Respond to of 2395

Rosemary, According to Yahoo, BICO has 316 million outstanding shares. Of that, almost 300 million are floating. There should be more dilution coming around the end of the year. BICO has 600 million authorized! We've discussed delisting on this thread before and the only info I've heard is that BICO was given an extension. The next quarterly report is due mid-November. That report will give a more clear picture of BICO's real status. Regards, Tom

To: Rosemary Soldberg who wrote (2163)	10/14/1998 9:04:00 PM
From: Tom R. Jones	Read Replies (2) \| Respond to of 2395

BICO is being De-Listed: <<Biocontrol To Trade On The Electronic Bulletin Board PITTSBURGH--(BUSINESS WIRE)--Oct. 14, 1998--Biocontrol Technology Inc. (OTCBB: BICO - news) announced today that effective Oct. 15, 1998, its common stock will trade on the electronic bulletin board under the same symbol, BICO. Biocontrol intends to immediately begin the appeal process for relisting on the Nasdaq Small-Cap Market, and has already begun to submit information that it believes will support its appeal. The company emphasizes that shareholders and brokers should not expect any change in their ability to execute transactions, since the bulletin board provides a fully-accessible and liquid market for trading. Biocontrol Technology Inc. (www.bico.com) has its corporate offices in Pittsburgh, and is involved in the development and manufacture of biomedical devices and environmental products. >>